# Sermorelin Meds

> A schematic reading room for the sermorelin literature — GHRH(1-29) research, traced.

## Pages

- [Sermorelin Meds — Independent research summaries on sermorelin acetate (GHRH 1-29)](/index.md): A schematic reading room for the sermorelin literature: 29-amino-acid GHRH(1-29) mechanism, the 1997 FDA approval and 2008 discontinuation, current 503A compounding status, and what the controlled trials actually show.
- [Sermorelin reported effects and safety — BOARD E·04](/effects.md): What the controlled trials measured, what research-use communities report, and the safety cautions that apply to sermorelin (GHRH 1-29). Evidence kept plainly distinct from anecdote.
- [Sermorelin research literature — mechanism, pediatric efficacy, adult somatopause trials](/research.md): A traced summary of the sermorelin research record: GHRH-R signaling cascade, 1996 pivotal pediatric trial, adult aging-axis controlled studies, GHRH-analog cognitive trials, and the GHRH-R receptor distribution that is widening the analog class beyond pituitary GH release.
- [Sermorelin dosing in the research and historic FDA-label record](/dosage.md): A documentation-only summary of sermorelin dosing as it appears in the historic FDA-approved pediatric label and in published adult research trials. Includes the 30 µg/kg pediatric regimen, the 1 µg/kg diagnostic stimulation test, and the adult somatopause research doses. Research context only — not a recommendation.
- [Sermorelin FAQ — research summaries on GHRH(1-29) acetate](/faq.md): Common reader questions about sermorelin: is it still made, why was the FDA-approved product discontinued, what is the half-life, how does it differ from rhGH, is it WADA-banned, and what does the research actually show.
- [Sermorelin references — full citation list with DOI and PubMed identifiers](/references.md): Complete reference list for the sermorelin research summaries on this site: 18 primary and review sources spanning the 1992 Corpas trial through 2025 reviews of GHRH-R signaling and the somatopause clinical context.
- [About Sermorelin Meds — editorial reading room for the GHRH(1-29) literature](/about.md): Sermorelin Meds is an independent editorial project that publishes summaries of the peer-reviewed research literature on sermorelin acetate. We are not a clinic. We do not sell anything. Editorial standards, sourcing methodology, and the modifier in the domain name explained.
- [Contact Sermorelin Meds — editorial corrections and reading-room inquiries](/contact.md): Contact the editorial team behind Sermorelin Meds for corrections, citation requests, or reading-room inquiries. Not a clinical service, not a pharmacy, and not for medical advice.